A detailed history of Pacer Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 410,463 shares of PFE stock, worth $11.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
410,463
Previous 1,646,672 75.07%
Holding current value
$11.3 Million
Previous $45.7 Million 74.87%
% of portfolio
0.03%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $31.2 Million - $36.6 Million
-1,236,209 Reduced 75.07%
410,463 $11.5 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $1.01 Million - $1.16 Million
39,023 Added 2.43%
1,646,672 $45.7 Million
Q4 2023

Jan 16, 2024

SELL
$26.13 - $33.94 $227 Million - $294 Million
-8,676,056 Reduced 84.37%
1,607,649 $46.3 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $77.4 Million - $90.5 Million
2,411,773 Added 30.64%
10,283,705 $341 Million
Q2 2023

Jul 12, 2023

BUY
$36.12 - $41.79 $33.8 Million - $39.1 Million
935,185 Added 13.48%
7,871,932 $289 Million
Q1 2023

May 02, 2023

BUY
$39.39 - $51.28 $102 Million - $133 Million
2,597,274 Added 59.85%
6,936,747 $283 Million
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $44.2 Million - $57.7 Million
1,057,958 Added 32.24%
4,339,473 $222 Million
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $31.3 Million - $38.2 Million
714,906 Added 27.85%
3,281,515 $144 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $35.4 Million - $41.9 Million
759,976 Added 42.07%
2,566,609 $135 Million
Q1 2022

Apr 05, 2022

BUY
$45.75 - $56.69 $48.8 Million - $60.5 Million
1,066,899 Added 144.23%
1,806,633 $93.5 Million
Q4 2021

Feb 03, 2022

SELL
$41.32 - $61.25 $2.93 Million - $4.34 Million
-70,832 Reduced 8.74%
739,734 $43.7 Million
Q3 2021

Oct 15, 2021

BUY
$39.25 - $50.42 $15.2 Million - $19.6 Million
387,780 Added 91.72%
810,566 $34.9 Million
Q2 2021

Jul 21, 2021

BUY
$35.91 - $40.68 $2.05 Million - $2.32 Million
57,102 Added 15.62%
422,786 $16.6 Million
Q1 2021

Apr 05, 2021

SELL
$33.49 - $37.77 $808,180 - $911,465
-24,132 Reduced 6.19%
365,684 $13.2 Million
Q4 2020

Jan 20, 2021

SELL
$33.47 - $42.56 $3.06 Million - $3.89 Million
-91,319 Reduced 18.98%
389,816 $14.3 Million
Q3 2020

Oct 19, 2020

SELL
$31.75 - $37.25 $2.41 Million - $2.83 Million
-75,883 Reduced 13.62%
481,135 $17.7 Million
Q2 2020

Jul 29, 2020

BUY
$30.12 - $36.54 $14.1 Million - $17.1 Million
467,110 Added 519.54%
557,018 $18.2 Million
Q1 2020

Apr 23, 2020

SELL
$27.03 - $38.62 $14.7 Million - $21 Million
-543,419 Reduced 85.8%
89,908 $3.32 Million
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $883,111 - $1 Million
26,826 Added 4.42%
633,327 $24.8 Million
Q3 2019

Oct 10, 2019

BUY
$32.49 - $42.13 $2.39 Million - $3.1 Million
73,592 Added 13.81%
606,501 $21.8 Million
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $1.29 Million - $1.45 Million
34,929 Added 7.01%
532,909 $23.1 Million
Q1 2019

Apr 10, 2019

BUY
$37.5 - $41.2 $18.7 Million - $20.5 Million
497,980 New
497,980 $21.1 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $16.2 Million - $18.5 Million
-422,231 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $937,756 - $1.14 Million
27,205 Added 6.89%
422,231 $18.6 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $1.98 Million - $2.11 Million
60,009 Added 17.91%
395,026 $14.3 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $2.13 Million - $2.47 Million
66,727 Added 24.87%
335,017 $11.9 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $1.85 Million - $1.96 Million
55,668 Added 26.18%
268,290 $9.72 Million
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $6.59 Million - $7.26 Million
212,622
212,622 $7.59 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.